Clinical trial
Liraglutide Actions on the Liver: Effects on Glucose Phosphorylation
NCT02198209 is registered in ClinicalTrials.gov with Cedars-Sinai Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Liraglutide Actions on the Liver: Effects on Glucose Phosphorylation
- Lead sponsor
- Cedars-Sinai Medical Center
- Phase
- Phase 4
- Overall status
- Withdrawn
- Start date
- December 31, 2019
- Completion date
- December 31, 2020
- Enrollment
- 0 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
type 2 diabetes